FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225751931> ?p ?o ?g. }

• W4225751931 endingPage "1689" @default.
• W4225751931 startingPage "1675" @default.
• W4225751931 abstract "Omega-3 (n–3) PUFAs are recognized for triglyceride-lowering effects in people with dyslipidemia, but it remains unclear if n–3-PUFA intake influences lipoprotein profiles in older adults without hypertriglyceridemia. The objective was to determine the effect of n–3-PUFA supplementation on plasma lipoprotein subfractions in healthy older men and women in the absence of cardiovascular disease (CVD) or hypertriglyceridemia. This was a secondary analysis and considered exploratory. Thirty young (20–35 y old) and 54 older (65–85 y old) men and women were enrolled in the study. Fasting plasma samples were collected. After baseline sample collection, 44 older adults were randomly assigned to receive either n–3-PUFA ethyl esters (3.9 g/d) or placebo (corn oil) for 6 mo. Pre- and postintervention plasma samples were used for quantitative lipoprotein subclass analysis using high-resolution proton NMR spectroscopy. The number of large, least-dense LDL particles decreased 17%–18% with n–3 PUFAs compared with placebo (<1% change; P < 0.01). The number of small, dense LDL particles increased 26%–44% with n–3 PUFAs compared with placebo (∼11% decrease; P < 0.01). The cholesterol content of large HDL particles increased by 32% with n–3 PUFAs and by 2% in placebo (P < 0.01). The cholesterol content of small HDL particles decreased by 23% with n–3 PUFAs and by 2% in placebo (P < 0.01). Despite increasing abundance of small, dense LDL particles that are associated with CVD risk, n–3 PUFAs reduced total triglycerides, maintained HDL, reduced systolic blood pressure, and shifted the HDL particle distribution toward a favorable cardioprotective profile in healthy older adults without dyslipidemia. This study suggests potential benefits of n–3-PUFA supplementation to lipoprotein profiles in healthy older adults without dyslipidemia, which should be considered when weighing the potential health benefits against the cost and ecological impact of widespread use of n–3-PUFA supplements. This trial was registered at clinicaltrials.gov as NCT03350906. J Nutr 2022;152:1675–1689." @default.
• W4225751931 created "2022-05-05" @default.
• W4225751931 creator A5021637559 @default.
• W4225751931 creator A5057206889 @default.
• W4225751931 creator A5073564494 @default.
• W4225751931 creator A5086048227 @default.
• W4225751931 date "2022-07-01" @default.
• W4225751931 modified "2023-10-16" @default.
• W4225751931 title "A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults" @default.
• W4225751931 cites W1647126819 @default.
• W4225751931 cites W1876608137 @default.
• W4225751931 cites W1975718861 @default.
• W4225751931 cites W1995883716 @default.
• W4225751931 cites W1996810831 @default.
• W4225751931 cites W2003767497 @default.
• W4225751931 cites W2015399076 @default.
• W4225751931 cites W2019453605 @default.
• W4225751931 cites W2027825904 @default.
• W4225751931 cites W2048070048 @default.
• W4225751931 cites W2053731083 @default.
• W4225751931 cites W2089440814 @default.
• W4225751931 cites W2103507414 @default.
• W4225751931 cites W2104680689 @default.
• W4225751931 cites W2104696876 @default.
• W4225751931 cites W2113332979 @default.
• W4225751931 cites W2114222555 @default.
• W4225751931 cites W2118528604 @default.
• W4225751931 cites W2126209927 @default.
• W4225751931 cites W2131094572 @default.
• W4225751931 cites W2131620744 @default.
• W4225751931 cites W2132556541 @default.
• W4225751931 cites W2132692611 @default.
• W4225751931 cites W2133738729 @default.
• W4225751931 cites W2135212903 @default.
• W4225751931 cites W2152086330 @default.
• W4225751931 cites W2155441427 @default.
• W4225751931 cites W2159689725 @default.
• W4225751931 cites W2167342561 @default.
• W4225751931 cites W2414466164 @default.
• W4225751931 cites W2604674779 @default.
• W4225751931 cites W2932545931 @default.
• W4225751931 cites W2952570920 @default.
• W4225751931 cites W2953972275 @default.
• W4225751931 cites W2969523838 @default.
• W4225751931 cites W3194262200 @default.
• W4225751931 doi "https://doi.org/10.1093/jn/nxac084" @default.
• W4225751931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35389487" @default.
• W4225751931 hasPublicationYear "2022" @default.
• W4225751931 type Work @default.
• W4225751931 citedByCount "5" @default.
• W4225751931 countsByYear W42257519312022 @default.
• W4225751931 countsByYear W42257519312023 @default.
• W4225751931 crossrefType "journal-article" @default.
• W4225751931 hasAuthorship W4225751931A5021637559 @default.
• W4225751931 hasAuthorship W4225751931A5057206889 @default.
• W4225751931 hasAuthorship W4225751931A5073564494 @default.
• W4225751931 hasAuthorship W4225751931A5086048227 @default.
• W4225751931 hasBestOaLocation W42257519311 @default.
• W4225751931 hasConcept C126322002 @default.
• W4225751931 hasConcept C134018914 @default.
• W4225751931 hasConcept C142724271 @default.
• W4225751931 hasConcept C159654299 @default.
• W4225751931 hasConcept C185592680 @default.
• W4225751931 hasConcept C19038510 @default.
• W4225751931 hasConcept C203014093 @default.
• W4225751931 hasConcept C204787440 @default.
• W4225751931 hasConcept C27081682 @default.
• W4225751931 hasConcept C2776194381 @default.
• W4225751931 hasConcept C2776919658 @default.
• W4225751931 hasConcept C2778096610 @default.
• W4225751931 hasConcept C2778163477 @default.
• W4225751931 hasConcept C2778913445 @default.
• W4225751931 hasConcept C2780072125 @default.
• W4225751931 hasConcept C2780516434 @default.
• W4225751931 hasConcept C2780948078 @default.
• W4225751931 hasConcept C3020261727 @default.
• W4225751931 hasConcept C43554185 @default.
• W4225751931 hasConcept C511355011 @default.
• W4225751931 hasConcept C543025807 @default.
• W4225751931 hasConcept C55493867 @default.
• W4225751931 hasConcept C71924100 @default.
• W4225751931 hasConceptScore W4225751931C126322002 @default.
• W4225751931 hasConceptScore W4225751931C134018914 @default.
• W4225751931 hasConceptScore W4225751931C142724271 @default.
• W4225751931 hasConceptScore W4225751931C159654299 @default.
• W4225751931 hasConceptScore W4225751931C185592680 @default.
• W4225751931 hasConceptScore W4225751931C19038510 @default.
• W4225751931 hasConceptScore W4225751931C203014093 @default.
• W4225751931 hasConceptScore W4225751931C204787440 @default.
• W4225751931 hasConceptScore W4225751931C27081682 @default.
• W4225751931 hasConceptScore W4225751931C2776194381 @default.
• W4225751931 hasConceptScore W4225751931C2776919658 @default.
• W4225751931 hasConceptScore W4225751931C2778096610 @default.
• W4225751931 hasConceptScore W4225751931C2778163477 @default.
• W4225751931 hasConceptScore W4225751931C2778913445 @default.
• W4225751931 hasConceptScore W4225751931C2780072125 @default.
• W4225751931 hasConceptScore W4225751931C2780516434 @default.
• W4225751931 hasConceptScore W4225751931C2780948078 @default.

• next